Curcumin for depression: a meta-analysis-Reference-Cited by-同舟云学术

Curcumin for depression: a meta-analysis

Published:2019-08-19 Issue:15 Volume:60 Page:2643-2653
ISSN:1040-8398
Container-title:Critical Reviews in Food Science and Nutrition
language:en
Short-container-title:Critical Reviews in Food Science and Nutrition

Author:

Fusar-Poli Laura¹^ORCID,Vozza Lucia¹,Gabbiadini Alberto¹,Vanella Antonio¹,Concas Ilaria¹,Tinacci Silvia¹,Petralia Antonino¹,Signorelli Maria Salvina¹,Aguglia Eugenio¹

Affiliation:

1. Department of Clinical and Experimental Medicine, Psychiatry Unit, University of Catania, Catania, Italy

Publisher

Informa UK Limited

Subject

Industrial and Manufacturing Engineering,General Medicine,Food Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/10408398.2019.1653260

Reference62 articles.

1. Cognitive functioning in the first-episode of major depressive disorder: A systematic review and meta-analysis.

2. The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials

3. Depression as a modifiable factor to decrease the risk of dementia

4. Diagnostic and Statistical Manual of Mental Disorders

5. Inhibition of monoamine oxidase A and B by demethoxycurcumin and bisdemethoxycurcumin

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased Systemic Monocyte Colony Protein-1 (MCP-1) Levels and Reduced sCD14 Levels in Curcumin-Treated Patients with Moderate Anxiety: A Pilot Study;Antioxidants;2024-08-29

2. The Role of Inflammation in Depression and Beyond: A Primer for Clinicians;Current Psychiatry Reports;2024-08-27

3. Progress of research on the treatment of depression by traditional Chinese medicine prescriptions;Heliyon;2024-08

4. Effect of curcumin supplementation on symptoms of anxiety: A systematic review and meta-analysis of randomized controlled trials;Clinical Nutrition ESPEN;2024-08

5. Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: a randomized double-blind clinical trial;Trials;2024-07-31